Sulfisoxazole acetyl - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for sulfisoxazole acetyl and what is the scope of patent protection?
Sulfisoxazole acetyl
is the generic ingredient in three branded drugs marketed by Roche and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for sulfisoxazole acetyl
| US Patents: | 0 |
| Tradenames: | 3 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 50 |
| DailyMed Link: | sulfisoxazole acetyl at DailyMed |
US Patents and Regulatory Information for sulfisoxazole acetyl
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roche | GANTRISIN PEDIATRIC | sulfisoxazole acetyl | SUSPENSION;ORAL | 009182-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Roche | GANTRISIN | sulfisoxazole acetyl | SYRUP;ORAL | 009182-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Roche | LIPO GANTRISIN | sulfisoxazole acetyl | EMULSION;ORAL | 009182-009 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
